Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
Location: Scarborough ME, The Bronx NY, Albany NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase 3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Westerly RI, Worcester MA, Waterford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase 2, Recruiting
A Study of ZW251 in Participants With Advanced Solid Tumors
for
Hepatocellular Carcinoma,
Location: New York NY, Hackensack NJ, Louisville KY,
Sponsor: Zymeworks BC Inc.
Sex: All
Age: 18+
Code: NCT07164313
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Moncton, Chicoutimi, New York NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Lutherville MD,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase 2, Recruiting
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE
Location: Portland ME, New Haven CT, Wilkes-Barre PA, Miami FL,
Sponsor: Vesalio
Sex: All
Age: 22+
Code: NCT06893588
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, Providence RI, The Bronx NY, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: New Haven CT, Hackensack NJ, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase 1, Phase 2, Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion